Treatments for Diabetic Retinopathy - Past, Present, and Future
An overview of the treatments for Diabetic Retinopath from the past, present, and future.
Nurse, Nurse Practitioner, Pharmacist, Pharmacy Technician, Physician, Physician Assistant
An overview of the various insights into the pathophysiology of DR, and clinical staging criteria An overview of treatment modalities, mechanisms of actions, and indications A look into current therapies, and recent clinical trials that help drive DR management decisions. A closer look into newer diabetes agents (specifically GLP-1 agonists) had any role in worsening or improving diabetic retinopathy. A deeper look at future treatments/ treatments undergoing clinical trials with vision-saving potential for our patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.25 contact hours.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.25 Attendance